0001209191-21-014749.txt : 20210226
0001209191-21-014749.hdr.sgml : 20210226
20210226162327
ACCESSION NUMBER: 0001209191-21-014749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21689225
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Chief Accounting Officer
Common Stock
2021-02-24
4
F
0
864
217.57
D
15964
D
Common Stock
2021-02-25
4
S
0
244
211.80
D
15720
D
Common Stock
2021-02-25
4
S
0
452
213.12
D
15268
D
Common Stock
2021-02-25
4
S
0
258
214.32
D
15010
D
Common Stock
2021-02-25
4
S
0
126
216.25
D
14884
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $211.80 (range $211.57 to $212.07).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.82 to $213.79).
Open market sales reported on this line occurred at a weighted average price of $214.32 (range $213.90 to $214.69).
Open market sales reported on this line occurred at a weighted average price of $216.25 (range $215.79 to $216.76).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-02-26